Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Henry Schein

How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Henry Schein Stock?

Although Henry Schein has underperformed the SPX over the past 12 months, analysts maintain a cautiously optimistic stance.

Barchart

Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Nasdaq Composite falling more than 350 points on Tuesday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Preview: What to Expect From Henry Schein’s Report

What should investors expect from Henry Schein’s upcoming Q3 report?

Barchart

Henry Schein Stock: Is HSIC Underperforming the Health Care Sector?

Henry Schein has underperformed the broader health care sector over the past year, and analysts remain moderately optimistic about the stock’s prospects.

Barchart

Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analyst

Henry Schein Inc (NASDAQ:HSIC) brass say global dental market growth remains steady, flat to low-single digits by region.

Benzinga

This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Henry Schein Stock Outlook: Is Wall Street Bullish or Bearish?

As a result of Henry Schein’s weak performance relative to the SPX over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Is Henry Schein Stock Outperforming the Dow?

Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.

Barchart

Henry Schein's Q1 2025 Earnings: What to Expect

Henry Schein is gearing up to announce its Q1 results in the upcoming month, and analysts expect a modest increase in earnings.

Barchart

Is Henry Schein Stock Underperforming the Nasdaq?

Although Henry Schein has lagged behind the Nasdaq Composite, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s future.

Barchart

Is Wall Street Bullish or Bearish on Henry Schein Stock?

Henry Schein has trailed the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on its future performance.

Barchart

The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts

Henry Schein (NASDAQ:HSIC) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Henry Schein outperformed its industry peers recently, and Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

The CEO trying to solve the dental care crisis

Stan Bergman, CEO of dental supply company Henry Schein, describes some of his efforts as “enlightened self-interest.”

Barchart

What Are Wall Street Analysts' Target Price for Henry Schein Stock?

As Henry Schein underperformed the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

TechRadar

Why are hackers targeting healthcare providers?

An exploration of why the healthcare sector has become a target for cyber attacks

StockNews.com

Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

Henry Schein (HSIC) posted solid third-quarter 2023 sales growth and non-GAAP EPS growth despite continued lower sales of PPE products and COVID-19 test kits. In addition, the company’s long-term outlook appears bright, driven by sustained demand for its healthcare solutions and strategic investments. So, is it worth adding this medical…

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Markets Today: Stock Index Futures Edge Lower as U.S. Shutdown Risks Linger

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.21%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.27%. Stock index futures this morning are moderately lower. Stocks are also under pressure this morning after Moody’s Investors Service late Friday cut its outlook on the U.S....

TechRadar

BlackCat strikes again - and this time it's breached a healthcare giant

Henry Schein is the latest victim of a ransomware attack, but it seems as if it paid its attackers.

Barchart

Stocks Retreat as Hawkish Fed Comments Push Bond Yields Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed down -0.67%. Stock indexes on Friday gave up early gains and...

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

Upgrades

Benzinga

Henry Schein's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Henry Schein (NASDAQ:HSIC) posted Q1 earnings of $186.00 million, an increase from Q4 of 22.25%. Sales dropped to $3.18 billion, a 4.56% decrease between quarters.

1 2

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Dow Jones Industrials

Palantir Technologies

239 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.